GlycoScoreDx Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

GlycoScoreDx General Information

Description

Developer of a cancer blood test intended to detect prostate cancer at an early stage. The company uses a combination of biomarkers to give a clear picture of clinically relevant prostate cancer, which can be adopted by any pathology laboratory and can be performed using existing infrastructure, enabling doctors to ensure that only patients with a clinically significant risk of the disease undergo the invasive procedure of painful prostate-tissue biopsy tests.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Sandgate House 102 Quayside
  • Tyne and Wear
  • Newcastle upon Tyne NE1 3DX
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Sandgate House 102 Quayside
  • Tyne and Wear
  • Newcastle upon Tyne NE1 3DX
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlycoScoreDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 12-May-2026 Completed Out of Business
5. Secondary Transaction - Private Completed Pre-Clinical Trials
4. Grant 01-Apr-2021 Completed Pre-Clinical Trials
3. Seed Round 01-Apr-2021 Completed Pre-Clinical Trials
2. Grant 30-Mar-2021 $499K Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2020 Completed Pre-Clinical Trials
To view GlycoScoreDx’s complete valuation and funding history, request access »

GlycoScoreDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
Ordinary
To view GlycoScoreDx’s complete cap table history, request access »

GlycoScoreDx Patents

GlycoScoreDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020391992-A1 Prostate cancer biomarkers Inactive 29-Nov-2019
EP-4065980-A1 Prostate cancer biomarkers Inactive 29-Nov-2019
GB-2594103-B Prostate cancer biomarkers Active 29-Nov-2019
GB-2595425-B Prostate cancer biomarkers Active 29-Nov-2019
US-20230003731-A1 Prostate cancer biomarkers Inactive 29-Nov-2019 G01N33/57555
To view GlycoScoreDx’s complete patent history, request access »

GlycoScoreDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlycoScoreDx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Newcastle University University
To view GlycoScoreDx’s complete investors history, request access »

GlycoScoreDx FAQs

  • When was GlycoScoreDx founded?

    GlycoScoreDx was founded in 2020.

  • Where is GlycoScoreDx headquartered?

    GlycoScoreDx is headquartered in Newcastle upon Tyne, United Kingdom.

  • What is the size of GlycoScoreDx?

    GlycoScoreDx has 2 total employees.

  • What industry is GlycoScoreDx in?

    GlycoScoreDx’s primary industry is Diagnostic Equipment.

  • Is GlycoScoreDx a private or public company?

    GlycoScoreDx is a Private company.

  • What is GlycoScoreDx’s current revenue?

    The current revenue for GlycoScoreDx is .

  • How much funding has GlycoScoreDx raised over time?

    GlycoScoreDx has raised $874K.

  • Who are GlycoScoreDx’s investors?

    Newcastle University has invested in GlycoScoreDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process